Skip to main content

Table 2 Demographic aspects and medical history of the included patients

From: Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study)

 

Month 0

Month 6

Number of patients

1490

1354

Age (years)

36.7 ± 0.3

36.8 ± 10.9

Sex (% males)

65.2 %

64.6 %

Marital status (% patients)

 Married or cohabiting

17.2 %

16.9 %

 Single

68.9 %

68.8 %

 Divorced, widowed, separated

13.9 %

14.3 %

Patients with children (% patients)

27.6 %

27.8 %

Accommodation (% patients)

  

 Independent housing

62.6

63.1

 Dependent housing

20.9

20.7

 Homeless housing

1.3 %

1.3 %

 Hotel

0.9 %

1.0 %

 Institutional center/Foundation

8.9 %

8.7 %

 Retiring home

0.5 %

0.6 %

 Other

4.8 %

4.7 %

Current employment status (% patients)

 Employee

12.2 %

11.7 %

 Student or in training

6.3 %

5.9 %

 Help Center for Labor

7.2 %

7.3 %

 Unemployed or retired

9.6 %

9.5 %

 Freelancer

1.0 %

1.1 %

 Disabled or sick leave for psychiatric disorder

56.4 %

57.0 %

 Status unknown

0.8 %

0.9 %

 Other

6.5 %

6.5 %

Psychiatric history

DSM-IV diagnostic (% patients)

 Schizophrenia

76.4 %

76.4 %

 Schizophreniform disorder

23.6 %

23.6 %

Chronicity (% patients)

 ≤ 5 years

30.7 %

30.3 %

 > 5 and ≤ 10 years

31.8 %

31.9 %

 > 10 and ≤ 15 years

16.6 %

16.6 %

 >15 years

20.8 %

21.2 %

  1. Values are given as mean ± SEM or as % of patients. M0, month 0 (inclusion). M6, month 6 (end of study)